Our patients, our passion.

Vivera was started with one mission in mind, to put our patients first.

Vivera Pharmaceuticals, Inc. is pleased to have an exclusive partnership with OmeCare, a leading CLIA-certified global clinical laboratory provider.  With results in 48 to 72 hours, the Vivera Pharmaceuticals + OmeCare specimen collection kits for COVID-19 are an ideal solution for patients who are unwilling or unable to visit their local clinic or healthcare provider.

Access to reliable testing allows for better patient management. By utilizing OmeCare’s dedicated CLIA-certified and CAP-accredited facility, Vivera and OmeCare are helping to eliminate excessive wait times.

Vivera Pharmaceuticals, Inc., is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, medical technologies and health and human service divisions, the Company has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with patented technology, manufacturing capabilities, and distribution.